PT - JOURNAL ARTICLE AU - Nicole Acosta AU - María A. Bautista AU - Barbara J. Waddell AU - Janine McCalder AU - Alexander Buchner Beaudet AU - Lawrence Man AU - Puja Pradhan AU - Navid Sedaghat AU - Chloe Papparis AU - Andra Bacanu AU - Jordan Hollman AU - Alexander Krusina AU - Danielle Southern AU - Tyler Williamson AU - Carmen Li AU - Srijak Bhatnagar AU - Sean Murphy AU - Jianwei Chen AU - Darina Kuzma AU - Jon Meddings AU - Jia Hu AU - Jason L. Cabaj AU - John M. Conly AU - Norma J. Ruecker AU - Gopal Achari AU - M. Cathryn Ryan AU - Kevin Frankowski AU - Casey R.J. Hubert AU - Michael D. Parkins TI - Longitudinal SARS-CoV-2 RNA Wastewater Monitoring Across a Range of Scales Correlates with Total and Regional COVID-19 Burden in a Well-Defined Urban Population AID - 10.1101/2021.11.19.21266588 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.19.21266588 4099 - http://medrxiv.org/content/early/2021/11/21/2021.11.19.21266588.short 4100 - http://medrxiv.org/content/early/2021/11/21/2021.11.19.21266588.full AB - Wastewater-based epidemiology (WBE) is an emerging surveillance tool that has been used to monitor the ongoing COVID-19 pandemic by tracking SARS-CoV-2 RNA shed into wastewater. WBE was performed to monitor the occurrence and spread of SARS-CoV-2 from three wastewater treatment plants (WWTP) and six neighborhoods in the city of Calgary, Canada (population 1.3 million). A total of 222 WWTP and 192 neighborhood samples were collected from June 2020 to May 2021, encompassing the end of the first-wave (June 2020), the second-wave (November end to December, 2020) and the third-wave of the COVID-19 pandemic (mid-April to May, 2021). Flow-weighted 24-hour composite samples were processed to extract RNA that was then analyzed for two SARS-CoV-2-specific regions of the nucleocapsid gene, N1 and N2, using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Using this approach SARS-CoV-2 RNA was detected in 98.06 % (406/414) of wastewater samples. SARS-CoV-2 RNA abundance was compared to clinically diagnosed COVID-19 cases organized by the three-digit postal code of affected individuals’ primary residences, enabling correlation analysis at neighborhood, WWTP and city-wide scales. Strong correlations were observed between N1 & N2 gene signals in wastewater and new daily cases for WWTPs and neighborhoods. Similarly, when flow rates at Calgary’s three WWTPs were used to normalize observed concentrations of SARS-CoV-2 RNA and combine them into a city-wide signal, this was strongly correlated with regionally diagnosed COVID-19 cases and clinical test percent positivity rate. Linked census data demonstrated disproportionate SARS-CoV-2 in wastewater from areas of the city with lower socioeconomic status and more racialized communities. WBE across a range of urban scales was demonstrated to be an effective mechanism of COVID-19 surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the Canadian Institute of Health Research [448242 to M.D.P.]; and Canadian Foundation for Innovation [41054 to C.R.J.H], as well as discretionary start-up funding from the Cumming School of Medicine Infectious Disease Section-Chief Fund (M.D.P.) and Campus Alberta Innovates Program Chair (C.R.J.H).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Federal data on social and ethnodemograhics data was collected from the Government of Canada's 2016 Federal Census.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is accessible from reasonable requests to the authors.Real-time data on SARS-CoV-2 RNA levels has been updated on the Cumming School of Medicine Centre for Health Informatics Website. https://covid-tracker.chi-csm.caBCoVBovine coronavirusCqquantification cycleNTCno-template controlPMMoVPepper mild mottle virusSARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2SESSocioeconomic statusVOCvariants of concernWBEwastewater-based epidemiologyWWTPwastewater treatment plant